Oxidative stress and endothelial dysfunction: Therapeutic implications
Open Access
- 24 January 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in Annals of Medicine
- Vol. 43 (4), 259-272
- https://doi.org/10.3109/07853890.2010.543920
Abstract
In a previous issue of Annals of Medicine, we presented evidence in support of the concept that an abnormally increased production of reactive oxygen species plays a central role in the genesis and progression of cardiovascular disease. While a number of preclinical lines of evidence support this concept, and despite the results of many studies suggesting a beneficial impact of antioxidant drugs on endothelial function, large clinical trials have failed to demonstrate a benefit of antioxidants on cardiovascular outcomes. Studies exploring the possibility that classical antioxidants such as vitamin C, vitamin E, selenium, or folic acid may improve the prognosis of patients with cardiac disease have substantially reported neutral—and occasionally negative—results. In contrast, medications such as statins, ACE inhibitors, certain β-blockers, or angiotensin I receptor blockers, which possess indirect ‘ancillary’ antioxidant properties, have been associated with beneficial effects in both preclinical studies and large clinical trials. The reasons for the failure of the ‘direct’ approach to antioxidant therapy, and for the success of the therapy with these drugs, are discussed in the present review.This publication has 100 references indexed in Scilit:
- Total and Cancer Mortality After Supplementation With Vitamins and Minerals: Follow-up of the Linxian General Population Nutrition Intervention TrialJNCI Journal of the National Cancer Institute, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Vitamins E and C in the Prevention of Cardiovascular Disease in MenJAMA, 2008
- Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary AngiographyJAMA, 2008
- Relation of Endothelial Function to Cardiovascular Risk in Women With Sedentary Occupations and Without Known Cardiovascular DiseaseThe American Journal of Cardiology, 2008
- Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular DiseaseJAMA, 2008
- A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in WomenArchives of Internal Medicine, 2007
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseThe New England Journal of Medicine, 1996